282 related articles for article (PubMed ID: 31004430)
21. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK.
Letang E; Lewis JJ; Bower M; Mosam A; Borok M; Campbell TB; Naniche D; Newsom-Davis T; Shaik F; Fiorillo S; Miro JM; Schellenberg D; Easterbrook PJ
AIDS; 2013 Jun; 27(10):1603-13. PubMed ID: 23462220
[TBL] [Abstract][Full Text] [Related]
22. An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease.
Uldrick TS; Wang V; O'Mahony D; Aleman K; Wyvill KM; Marshall V; Steinberg SM; Pittaluga S; Maric I; Whitby D; Tosato G; Little RF; Yarchoan R
Clin Infect Dis; 2010 Aug; 51(3):350-8. PubMed ID: 20583924
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for Kaposi's sarcoma among HIV-positive individuals in a case control study in Cameroon.
Stolka K; Ndom P; Hemingway-Foday J; Iriondo-Perez J; Miley W; Labo N; Stella J; Abassora M; Woelk G; Ryder R; Whitby D; Smith JS
Cancer Epidemiol; 2014 Apr; 38(2):137-43. PubMed ID: 24631417
[TBL] [Abstract][Full Text] [Related]
24. Risk factors influencing antibody responses to Kaposi's sarcoma-associated herpesvirus latent and lytic antigens in patients under antiretroviral therapy.
Guadalupe M; Pollock BH; Westbrook S; Redding S; Bullock D; Anstead G; Agan BK; Marconi VC; Barbieri S; Sankar V; Rebeles J; Flahive Y; Schoolfield J; Wang L; Lei X; Dow D; Yeh CK; Dang H; Infante AJ; Gao SJ
J Acquir Immune Defic Syndr; 2011 Jan; 56(1):83-90. PubMed ID: 21084997
[TBL] [Abstract][Full Text] [Related]
25. Runaway Kaposi Sarcoma-associated herpesvirus replication correlates with systemic IL-10 levels.
Caro-Vegas C; Sellers S; Host KM; Seltzer J; Landis J; Fischer WA; Damania B; Dittmer DP
Virology; 2020 Jan; 539():18-25. PubMed ID: 31629226
[TBL] [Abstract][Full Text] [Related]
26. Reactivation of Kaposi's sarcoma-associated herpesvirus (KSHV) by SARS-CoV-2 in non-hospitalised HIV-infected patients.
Lambarey H; Blumenthal MJ; Chetram A; Joyimbana W; Jennings L; Orrell C; Schäfer G
EBioMedicine; 2024 Feb; 100():104986. PubMed ID: 38306893
[TBL] [Abstract][Full Text] [Related]
27. Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group.
Chang Y; Ziegler J; Wabinga H; Katangole-Mbidde E; Boshoff C; Schulz T; Whitby D; Maddalena D; Jaffe HW; Weiss RA; Moore PS
Arch Intern Med; 1996 Jan; 156(2):202-4. PubMed ID: 8546554
[TBL] [Abstract][Full Text] [Related]
28. Kaposi sarcoma-associated herpesvirus, HIV-1 and Kaposi sarcoma risk in black South Africans diagnosed with cancer during antiretroviral treatment rollout.
Motlhale M; Muchengeti M; Bradshaw D; Chen WC; Singini MG; de Villiers CB; Lewis CM; Bender N; Mathew CG; Newton R; Waterboer T; Singh E; Sitas F
Int J Cancer; 2023 May; 152(10):2081-2089. PubMed ID: 36727526
[TBL] [Abstract][Full Text] [Related]
29. Similar Immunological Profiles Between African Endemic and Human Immunodeficiency Virus Type 1-Associated Epidemic Kaposi Sarcoma (KS) Patients Reveal the Primary Role of KS-Associated Herpesvirus in KS Pathogenesis.
Lidenge SJ; Tso FY; Ngalamika O; Ngowi JR; Mortazavi Y; Kwon EH; Shea DM; Minhas V; Mwaiselage J; Wood C; West JT
J Infect Dis; 2019 Apr; 219(8):1318-1328. PubMed ID: 30452681
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of patients admitted to the ICU with Kaposi sarcoma herpesvirus-associated diseases.
Hansen ME; Mangusan R; Lurain K; Odeny T; George J; Lu C; Manion M; Widell A; Ekwede I; Whitby D; Gulley JL; Kadri SS; Elinoff JM; Barochia A; Torabi-Parizi P; Uldrick TS; Yarchoan R; Ramaswami R
AIDS; 2022 Nov; 36(14):1969-1978. PubMed ID: 35848586
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.
Ziegler JL; Newton R; Katongole-Mbidde E; Mbulataiye S; De Cock K; Wabinga H; Mugerwa J; Katabira E; Jaffe H; Parkin DM; Reeves G; Weiss R; Beral V
AIDS; 1997 Nov; 11(13):1619-26. PubMed ID: 9365767
[TBL] [Abstract][Full Text] [Related]
32. A novel mathematical model of AIDS-associated Kaposi's sarcoma: Analysis and optimal control.
Kaondera-Shava RF; Lungu E; Szomolay B
Biosystems; 2021 Feb; 200():104318. PubMed ID: 33309554
[TBL] [Abstract][Full Text] [Related]
33. Kaposi's Sarcoma-Associated Herpesvirus Infection of Neurons in HIV-Positive Patients.
Tso FY; Sawyer A; Kwon EH; Mudenda V; Langford D; Zhou Y; West J; Wood C
J Infect Dis; 2017 Jun; 215(12):1898-1907. PubMed ID: 27932611
[TBL] [Abstract][Full Text] [Related]
34. Kaposi's Sarcoma-Associated Herpesvirus, but Not Epstein-Barr Virus, Co-infection Associates With Coronavirus Disease 2019 Severity and Outcome in South African Patients.
Blumenthal MJ; Lambarey H; Chetram A; Riou C; Wilkinson RJ; Schäfer G
Front Microbiol; 2021; 12():795555. PubMed ID: 35069495
[TBL] [Abstract][Full Text] [Related]
35. A Fatal Case of Kaposi Sarcoma Immune Reconstitution Syndrome (KS-IRIS) Complicated by Kaposi Sarcoma Inflammatory Cytokine Syndrome (KICS) or Multicentric Castleman Disease (MCD): A Case Report and Review.
Dumic I; Radovanovic M; Igandan O; Savic I; Nordstrom CW; Jevtic D; Subramanian A; Ramanan P
Am J Case Rep; 2020 Dec; 21():e926433. PubMed ID: 33268763
[TBL] [Abstract][Full Text] [Related]
36. Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-Infected patients receiving highly active antiretroviral therapy.
Wilkinson J; Cope A; Gill J; Bourboulia D; Hayes P; Imami N; Kubo T; Marcelin A; Calvez V; Weiss R; Gazzard B; Boshoff C; Gotch F
J Virol; 2002 Mar; 76(6):2634-40. PubMed ID: 11861829
[TBL] [Abstract][Full Text] [Related]
37. Viral profiling identifies multiple subtypes of Kaposi's sarcoma.
Hosseinipour MC; Sweet KM; Xiong J; Namarika D; Mwafongo A; Nyirenda M; Chiwoko L; Kamwendo D; Hoffman I; Lee J; Phiri S; Vahrson W; Damania B; Dittmer DP
mBio; 2014 Sep; 5(5):e01633-14. PubMed ID: 25249280
[TBL] [Abstract][Full Text] [Related]
38. Restricted Kaposi's sarcoma (KS) herpesvirus transcription in KS lesions from patients on successful antiretroviral therapy.
Dittmer DP
mBio; 2011; 2(6):e00138-11. PubMed ID: 22045987
[TBL] [Abstract][Full Text] [Related]
39. Association of Kaposi's sarcoma associated herpesvirus (KSHV) DNA in bronchoalveolar lavage fluid of HIV infected individuals with bronchoscopically diagnosed tracheobronchial Kaposi's sarcoma.
Howard MR; Brink NS; Whitby D; Tedder RS; Miller RF
Sex Transm Infect; 1998 Feb; 74(1):27-31. PubMed ID: 9634297
[TBL] [Abstract][Full Text] [Related]
40. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma.
Gao SJ; Kingsley L; Hoover DR; Spira TJ; Rinaldo CR; Saah A; Phair J; Detels R; Parry P; Chang Y; Moore PS
N Engl J Med; 1996 Jul; 335(4):233-41. PubMed ID: 8657239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
